In addition, disruption of Smad3 prevents angiotensin II-induced kidney injury by preserving renal function, inhibiting renal fibrosis and inflammation, but has no effect on angiotensin II-induced high blood pressure in vivo [71]. The gene discussed is AGT; the disease is renal fibrosis.